健康个体和COVID-19感染康复个体的肺泡死腔和肺内分流

IF 2.8 4区 医学 Q2 PHYSIOLOGY
Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins
{"title":"健康个体和COVID-19感染康复个体的肺泡死腔和肺内分流","authors":"Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins","doi":"10.1113/EP092971","DOIUrl":null,"url":null,"abstract":"<p><p>Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇V<sub>D,alv</sub>/̇V<sub>T</sub>) and intrapulmonary shunt (̇Q<sub>s</sub>/̇Q<sub>T</sub>) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub>, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar <math> <semantics><msub><mi>P</mi> <mrow><mi>C</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${P_{{\\mathrm{C}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> and <math> <semantics><msub><mi>P</mi> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${P_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub> were calculated. Mean ̇V<sub>D,alv</sub>/̇V<sub>T</sub> was 0.115 ± 0.062 and mean ̇Q<sub>s</sub>/̇Q<sub>T</sub> was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇V<sub>D,alv</sub>/̇V<sub>T</sub> or ̇Q<sub>s</sub>/̇Q<sub>T</sub>, although if severity was instead treated as an interval measure, then a small increase in ̇Q<sub>s</sub>/̇Q<sub>T</sub> with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub>, whereas no participant exceeded the originally proposed upper limit for ̇Q<sub>s</sub>/̇Q<sub>T</sub>. We conclude that prior infection with COVID-19 had no effect on ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and little effect on ̇Q<sub>s</sub>/̇Q<sub>T</sub>, and that the supposedly high values of ̇V<sub>D,alv</sub>/̇V<sub>T</sub> are within the normal range.</p>","PeriodicalId":12092,"journal":{"name":"Experimental Physiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alveolar deadspace and intrapulmonary shunt in healthy individuals and in individuals who have recovered from COVID-19 infection.\",\"authors\":\"Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins\",\"doi\":\"10.1113/EP092971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇V<sub>D,alv</sub>/̇V<sub>T</sub>) and intrapulmonary shunt (̇Q<sub>s</sub>/̇Q<sub>T</sub>) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub>, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar <math> <semantics><msub><mi>P</mi> <mrow><mi>C</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${P_{{\\\\mathrm{C}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> and <math> <semantics><msub><mi>P</mi> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${P_{{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub> were calculated. Mean ̇V<sub>D,alv</sub>/̇V<sub>T</sub> was 0.115 ± 0.062 and mean ̇Q<sub>s</sub>/̇Q<sub>T</sub> was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇V<sub>D,alv</sub>/̇V<sub>T</sub> or ̇Q<sub>s</sub>/̇Q<sub>T</sub>, although if severity was instead treated as an interval measure, then a small increase in ̇Q<sub>s</sub>/̇Q<sub>T</sub> with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub>, whereas no participant exceeded the originally proposed upper limit for ̇Q<sub>s</sub>/̇Q<sub>T</sub>. We conclude that prior infection with COVID-19 had no effect on ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and little effect on ̇Q<sub>s</sub>/̇Q<sub>T</sub>, and that the supposedly high values of ̇V<sub>D,alv</sub>/̇V<sub>T</sub> are within the normal range.</p>\",\"PeriodicalId\":12092,\"journal\":{\"name\":\"Experimental Physiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental Physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1113/EP092971\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1113/EP092971","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在急性COVID-19感染后,据报道未接种疫苗的患者表现出肺泡死亡空间(VD、alv/ VT)和肺内分流(Qs/ QT)分数升高。然而,由于存在不确定性,因此我们试图从先前报道的单独的COVID-19患者队列中复制研究结果,其中包括从未感染过COVID-19的健康对照组。研究人员使用了来自81名参与者的数据,这些参与者根据先前感染COVID-19的严重程度分为四组。所有参与者都抽取了动脉血气样本,同时对他们的呼吸气体交换进行了高度精确的测量。利用气体交换数据估算肺泡pc2o ${P_{\mathrm{C}}{{\mathrm{O}}_2}}}$和p2o ${P_{{\mathrm{O}}_2}}}$,并与相应的动脉血气值之间的差异提供肺泡-动脉梯度,由此计算出肺泡-动脉梯度的VD、alv/ VT和Qs/ QT。平均VD、alv/ VT为0.115±0.062,平均Qs/ QT为0.014±0.011。两组(包括未感染的对照组)之间没有检测到明显的VD、alv/ VT或Qs/ QT,尽管如果将严重程度作为间隔测量,那么可以检测到随着严重程度的增加而出现的轻微的Qs/ QT增加(P = 0.00934)。许多参与者,包括对照组,超过了最初建议的正常上限,而没有参与者超过了最初建议的上限,即氧含量(VD),氧含量(alv) /氧含量(VT)。我们认为,既往感染COVID-19对患者的VD、alv/ VT无影响,对qqs / QT的影响较小,推测较高的VD、alv/ VT值在正常范围内。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Alveolar deadspace and intrapulmonary shunt in healthy individuals and in individuals who have recovered from COVID-19 infection.

Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇VD,alv/̇VT) and intrapulmonary shunt (̇Qs/̇QT) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇VD,alv/̇VT and ̇Qs/̇QT, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar P C O 2 ${P_{{\mathrm{C}}{{\mathrm{O}}_2}}}$ and P O 2 ${P_{{{\mathrm{O}}_2}}}$ , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇VD,alv/̇VT and ̇Qs/̇QT were calculated. Mean ̇VD,alv/̇VT was 0.115 ± 0.062 and mean ̇Qs/̇QT was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇VD,alv/̇VT or ̇Qs/̇QT, although if severity was instead treated as an interval measure, then a small increase in ̇Qs/̇QT with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇VD,alv/̇VT, whereas no participant exceeded the originally proposed upper limit for ̇Qs/̇QT. We conclude that prior infection with COVID-19 had no effect on ̇VD,alv/̇VT and little effect on ̇Qs/̇QT, and that the supposedly high values of ̇VD,alv/̇VT are within the normal range.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Experimental Physiology
Experimental Physiology 医学-生理学
CiteScore
5.10
自引率
3.70%
发文量
262
审稿时长
1 months
期刊介绍: Experimental Physiology publishes research papers that report novel insights into homeostatic and adaptive responses in health, as well as those that further our understanding of pathophysiological mechanisms in disease. We encourage papers that embrace the journal’s orientation of translation and integration, including studies of the adaptive responses to exercise, acute and chronic environmental stressors, growth and aging, and diseases where integrative homeostatic mechanisms play a key role in the response to and evolution of the disease process. Examples of such diseases include hypertension, heart failure, hypoxic lung disease, endocrine and neurological disorders. We are also keen to publish research that has a translational aspect or clinical application. Comparative physiology work that can be applied to aid the understanding human physiology is also encouraged. Manuscripts that report the use of bioinformatic, genomic, molecular, proteomic and cellular techniques to provide novel insights into integrative physiological and pathophysiological mechanisms are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信